Cardizem Monovial Interactions
There are 694 drugs known to interact with Cardizem Monovial (diltiazem), along with 9 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 115 are major, 521 are moderate, and 58 are minor.
- View all 694 medications that may interact with Cardizem Monovial
- View Cardizem Monovial alcohol/food interactions (1)
- View Cardizem Monovial disease interactions (9)
Most frequently checked interactions
View interaction reports for Cardizem Monovial (diltiazem) and the medicines listed below.
- acyclovir
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- Antioxidant Formula (multivitamin with minerals)
- aripiprazole
- Atrovent (ipratropium)
- BuSpar (buspirone)
- Calcium, Magnesium and Zinc (multivitamin with minerals)
- citalopram
- Cytomel (liothyronine)
- demeclocycline
- dexamethasone
- Effexor (venlafaxine)
- Emgality (galcanezumab)
- escitalopram
- Gabarone (gabapentin)
- hydrocodone
- Iron Sulfate (ferrous sulfate)
- Lamictal (lamotrigine)
- levetiracetam
- lorazepam
- Lunesta (eszopiclone)
- montelukast
- potassium gluconate
- prednisone
- prochlorperazine
- progesterone
- Provigil (modafinil)
- Samsca (tolvaptan)
- Seroquel (quetiapine)
Cardizem Monovial alcohol/food interactions
There is 1 alcohol/food interaction with Cardizem Monovial (diltiazem).
Cardizem Monovial disease interactions
There are 9 disease interactions with Cardizem Monovial (diltiazem) which include:
- aortic stenosis
- bradyarrhythmia/AV block
- cardiogenic shock/hypotension
- coronary artery disease
- liver disease
- CHF/AMI
- accessory AV tracts
- ventricular tachycardia
- renal dysfunction
More about Cardizem Monovial (diltiazem)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcium channel blockers
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.